Evaluation of Oral Anti-Diabetic Agents as Initial Therapy for Recently Diagnosed Type 2 Diabetes Patients with Severe Hyperglycemia

被引：0
|
作者：
Makkar, Brij M.
Harichandan, Narmarata
Sharma, Pratima
机构：
来源：
DIABETES | 2010年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A561 / A562
页数：2
相关论文
共 50 条
  • [31] Change of initial oral antidiabetic therapy in type 2 diabetic patients
    Arian Plat
    Fernie Penning-van Beest
    Sophia Kessabi
    Martijn Groot
    Ron Herings
    Pharmacy World & Science, 2009, 31 : 622 - 626
  • [32] Factors Affecting Dose Escalation of Anti-Diabetic Drugs in Type 2 Diabetes Patients
    Akash
    Shenoy, Ashok K.
    Adhikari, M. R. Prabha
    Hadigal, Sanjay
    Kamath, Priyanka
    Nishith, R. S.
    INDIAN JOURNAL OF PHARMACOLOGY, 2013, 45 : S63 - S64
  • [33] Compliance With Anti-Diabetic Medication Improves Cardiovascular Outcomes in Patients With Type 2 Diabetes
    Hong, Sangmo
    Kim, Kyungjoo
    Kim, Mi Kyung
    Woo, Jeong-Taek
    Kim, Young Seol
    Baik, Sei Hyun
    Nam, Moon Suk
    Lee, Kwan Woo
    Kim, Jinhee
    Kim, Yuri
    Park, Yongsoo
    DIABETES, 2013, 62 : A372 - A372
  • [34] The determinants of anti-diabetic medication adherence based on the experiences of patients with type 2 diabetes
    Laleh Dehdari
    Tahereh Dehdari
    Archives of Public Health, 77
  • [35] The determinants of anti-diabetic medication adherence based on the experiences of patients with type 2 diabetes
    Dehdari, Laleh
    Dehdari, Tahereh
    ARCHIVES OF PUBLIC HEALTH, 2019, 77 (1)
  • [36] Prescription trends and the selection of initial oral antidiabetic agents for patients with newly diagnosed type 2 diabetes: a nationwide study
    Liu, C. -H.
    Chen, S. -T.
    Chang, C. -H.
    Chuang, L. -M.
    Lai, M. -S.
    PUBLIC HEALTH, 2017, 152 : 20 - 27
  • [37] Major anti-diabetic effect of gynostemma pentaphyllum tea in patients with type 2 diabetes
    Huyen, Vu T.
    Phan, Dao V.
    Thang, Pham
    Hoa, Nguyen K.
    Ostenson, Claes-Goran
    DIABETES, 2008, 57 : A151 - A151
  • [38] Metabolic changes induced by dapagliflozin, an SGLT2 inhibitor, in Japanese patients with type 2 diabetes treated by oral anti-diabetic agents: A randomized, clinical trial
    Horibe, Kayo
    Morino, Katsutaro
    Miyazawa, Itsuko
    Tanaka-Mizuno, Sachiko
    Kondo, Keiko
    Sato, Daisuke
    Ohashi, Natsuko
    Ida, Shogo
    Yanagimachi, Tsuyoshi
    Yoshimura, Masahiro
    Itoh, Ryuta
    Murata, Kiyoshi
    Miura, Katsuyuki
    Arima, Hisatomi
    Fujita, Yukihiro
    Ugi, Satoshi
    Maegawa, Hiroshi
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 186
  • [39] Hepatitis B/C Don't Affect the Pioglitazone Effects in Type 2 Diabetic Patients Treated with Other Oral Anti-Diabetic Agents
    Lin, Knu-Der
    Shin, Shyi-Jang
    He, Sin-Ru
    Li, Mei-Yue
    Chang, Yu-Hung
    Hsiao, Pi-Jung
    DIABETES, 2009, 58 : A526 - A526
  • [40] A Comparative Role of Oral and Parenteral Anti-Diabetic Agents in Diabetic patients with Acute Myocardial Infarction
    Firdous, Kanwal
    Siddiqui, Maria F.
    Shuja, Naveed
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2016, 10 (03): : 1028 - 1030
12345